Medical Affairs Fellowships
Mercer University College of Pharmacy has partnered with Arbor Pharmaceuticals and Galt Pharmaceuticals to offer two separate Medical Affairs Fellowships in metro Atlanta. Representatives from Mercer, Arbor and Galt traditionally attend ASHP’s Midyear Clinical Meeting and Exhibition and interview applicants through the Personnel Placement Service. Due to the COVID-19 pandemic, interviews will be virtual. Please read below for more details. If applicants have questions, please contact Dr. Lorenzo Villa Zapata at firstname.lastname@example.org.
Fellows will divide their time between the College and their respective pharmaceutical company, where they will help advance the clinical development of various products and support medical and scientific affairs as products move from development to commercialization. These fellowships are primarily designed to provide the candidate with in-depth experience in medical affairs and will focus on development of skills that will be valuable as graduates transition into a career in the pharmaceutical industry. Fellows will also have the opportunity to work with Mercer faculty on research projects. In addition, they will have opportunity to participate in teaching activities in the College’s Doctor of Pharmacy (Pharm.D.) didactic program.
Applications from candidates in a Pharm.D. degree program or a graduate degree program are sought for the July 2022– June 2023 cycle. Applications must include:
- letter of intent
- curriculum vitae
- an unofficial transcript from graduate/professional degree program (Official transcripts will be required upon acceptance into the fellowship program to confirm degree conferral.)
- letters of recommendation from two references.
Applicants attending ASHP 2020 must sign-up for the Personnel Placement Service and submit materials through the portal. Applicants unable to attend ASHP must email materials to email@example.com by Dec. 11, 2020.
Arbor Pharmaceuticals is a specialty pharmaceutical company that markets more than 20 FDA-approved products in multiple therapeutic areas, including cardiovascular, neuroscience, pediatric, endocrinology and hospital markets. Arbor was acquired by Mercer alumnus Ed Schutter, BSPHARM ‘77, MBA, and two other investors in 2010. Since acquisition, the company has grown from less than $2 million in annual sales to more than $250 million. The company is led by a management team with extensive pharmaceutical industry experience in clinical development, medical and regulatory affairs, manufacturing, quality control and commercialization.
The company currently employs numerous M.D.s, Ph.D.s, Pharm.D.s, nurses and other scientists who work in medical, clinical or regulatory affairs, manufacturing, quality control, managed markets and commercial operations. Fellows will work primarily within the Arbor Pharmaceuticals medical department, led by Evan Scullin, M.D. Fellows will likely be involved in projects ranging from medical information, medical strategy, drug safety investigations and research of new development or in-licensing opportunities. For more information regarding Arbor Pharmaceuticals or any of its products, please visit www.arborpharma.com.
Applicants attending ASHP 2021 must sign-up for the Personnel Placement Service and submit materials through the portal. Applicants unable to attend ASHP must email materials to firstname.lastname@example.org by Nov. 14, 2021. Letter of recommendations must be received by Dec 1, 2021.
Galt Pharmaceuticals is a unique pharmaceutical company that seeks to serve unmet needs within health care. The company applies pharmaceutical, managed care and marketing expertise to develop, license and acquire pharmaceutical products for distribution, partnering with independent pharmacies to deliver patient-centered, community-driven care. Galt is the first and only pharmaceutical company to utilize a franchise model, trademarked as “phranchise,” allowing for entrepreneurs the opportunity to build their own pharmaceutical business locally, rather than the centralized, corporate model of traditional pharma.
The fellowship is a one-year experience concentrated in medical affairs, involving various experiences in medical information, scientific communications and field medical support. Fellows also will have the opportunity to be involved in cross-functional projects with regulatory, marketing and commercial operations. In addition, the chosen applicant will work alongside Galt’s two cofounders, CEO Barry Patel, PHARMD ‘92, who co-founded and later sold the pharmaceutical outcomes research and education company Total Therapeutic Management and chairman Wade Smith, PHARMD ‘88, both of whom are Mercer graduates.